| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.40B | 1.60B | 1.50B | 1.24B | 681.72M |
| Gross Profit | 1.31B | 523.19M | 167.88M | 139.50M | 236.86M |
| EBITDA | 1.24B | 448.95M | 158.48M | 122.41M | 265.95M |
| Net Income | 830.43M | 211.14M | 51.45M | 50.34M | 138.68M |
Balance Sheet | |||||
| Total Assets | 6.53B | 4.59B | 4.55B | 3.65B | 3.90B |
| Cash, Cash Equivalents and Short-Term Investments | 749.20M | 172.33M | 157.89M | 143.10M | 157.70M |
| Total Debt | 514.51M | 533.58M | 565.36M | 161.54M | 179.77M |
| Total Liabilities | 2.36B | 1.97B | 2.09B | 1.62B | 1.72B |
| Stockholders Equity | 3.99B | 2.48B | 2.32B | 1.89B | 2.02B |
Cash Flow | |||||
| Free Cash Flow | 513.65M | 270.57M | -141.56M | 31.71M | 115.96M |
| Operating Cash Flow | 981.47M | 508.35M | -35.50M | 133.56M | 217.31M |
| Investing Cash Flow | -401.88M | -252.16M | -1.38M | -100.65M | -101.69M |
| Financing Cash Flow | -105.68M | -240.54M | 62.51M | -42.99M | -91.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$15.73B | 14.89 | 23.61% | 0.44% | 49.31% | 262.43% | |
70 Outperform | HK$104.08B | 27.53 | 11.01% | 0.16% | 56.67% | 139.25% | |
64 Neutral | HK$31.46B | 6.03 | 33.81% | 1.40% | 10.57% | 112.84% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | HK$178.98B | 33.06 | ― | 0.93% | ― | ― | |
54 Neutral | HK$4.49B | 21.71 | 18.35% | ― | 59.18% | 28.00% | |
40 Underperform | HK$798.66M | -31.17 | -1.02% | ― | ― | -25.51% |